Publications
- An immunotherapy effect analysis in Rasmussen encephalitis2020 | Second Faculty of Medicine, First Faculty of Medicine
- Phase I/II trial of dendritic cell-based active cellular immunotherapy with DCVAC/PCa in patients with rising PSA after primary prostatectomy or salvage radiotherapy for the treatment of prostate cancer2018 | Second Faculty of Medicine, First Faculty of Medicine
- NF-kappa B, p38 MAPK, ERK1/2, mTOR, STAT3 and increased glycolysis regulate stability of paricalcitol/dexamethasone-generated tolerogenic dendritic cells in the inflammatory environment2015 | Second Faculty of Medicine
- Phase I/II clinical trial of dendritic-cell based immunotherapy (DCVAC/PCa) combined with chemotherapy in patients with metastatic, castration-resistant prostate cancer2015 | Second Faculty of Medicine
- Regulatory T cells, dendritic cells and neutrophils in patients with renal cell carcinoma2013 | Second Faculty of Medicine
- Options cancer immunotherapy for prostate cancer2010 | Second Faculty of Medicine
- Changes in innate and adaptive immunity over the first year after the onset of type 1 diabetes2020 | Second Faculty of Medicine, Faculty of Mathematics and Physics
- Selhání střeva u dětí2020 | Second Faculty of Medicine, Central Library of Charles University
- Enhanced STAT3 phosphorylation and PD-L1 expression in myeloid dendritic cells indicate impaired IL-27Ralpha signaling in type 1 diabetes2020 | Second Faculty of Medicine
- Paediatric onset of multiple sclerosis: Analysis of chemokine and cytokine levels in the context of the early clinical course2020 | Second Faculty of Medicine
Loading network view...